616 results on '"López-Campos, José Luis"'
Search Results
102. Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD
103. Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
104. Consenso sobre el diagnóstico, tratamiento y seguimiento de la EPOC: Grupo de trabajo EPOC Forum
105. Effectiveness of aprepitant in post‐acute COVID19 syndrome
106. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD
107. WITHDRAWN: Deconstructing phenotypes in COPD: An analysis of the TRACE cohort
108. Importancia de la fatiga, calidad del sueño y estado de ánimo en los pacientes con EPOC y la necesidad de disponer de instrumentos para su medición
109. Revista del año de la EPOC
110. Habilitando el Abordaje en la Comunidad de las Enfermedades Respiratorias (HACER) EPOC
111. Presencia de miembros de SEPAR en los Comités Editoriales de revistas indexadas en la categoría «Respiratory System» de Journal Citation Reports
112. Presence of SEPAR members on the editorial committees of journals indexed in the “Respiratory System” category of Journal Citation Reports
113. Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
114. Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
115. Escalas pronósticas de morbimortalidad por COVID-19: necesarias pero también fiables
116. Mortalidad por cáncer de pulmón en España. Evolución en 25 años (1980-2005)
117. Transculturally adapted Spanish SRI questionnaire for home mechanically ventilated patients was viable, valid, and reliable
118. Lung Cancer Mortality Trends in Spain Between 1980 and 2005
119. Shuttle walking versus maximal cycle testing: Clinical correlates in patients with kyphoscoliosis
120. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges
121. Chapter 36 - Phenotyping COPD
122. CPAP titration: Different methods for similar clinical results
123. Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD
124. Phenotypic characterisation of early COPD: a prospective case–control study
125. Health-Related Quality of Life of Patients Receiving Home May Mechanical Ventilation: The Spanish Version of the Severe Respiratory Insufficiency Questionnaire
126. Biomarkers to predict FEV1 decline in smokers and early-onset COPD
127. Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD
128. Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy
129. The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency
130. Cellular Mechanisms Involved in the Pathogenesis of Airway Remodeling in Chronic Lung Disease
131. La prescripción con visado de la triple terapia en combinación a dosis fija en España
132. Coping With Low Mortality and Exacerbation Rate Differences Between COPD Triple Therapy Studies, and a Proposal for Upcoming Studies
133. Controlled Prescription of Triple Fixed-Dose Combination Therapy in Spain
134. Guía SEPAR de las terapias respiratorias domiciliarias, 2020
135. Diagnostic Performance of a Lateral Flow Assay for the Detection of Alpha-1-Antitrypsin Deficiency
136. International trends in COPD mortality, 1995–2017
137. Ten Research Questions for Improving COPD Care in the Next Decade
138. High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study
139. Status of and strategies for improving adherence to COPD treatment
140. Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study (PLOS ONE (2018) 13:6 (e0198777) DOI: 10.1371/journal.pone.0198777)
141. [Translated article] ANTES Program: One Year on
142. ANTES: Un año después en la EPOC
143. Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort
144. Use of inhaled corticoids and presence of eosinophilia in patients with COPD: TRACE Cohort
145. Lung Growth and Aging: A Complex and Increasingly Confounding Network
146. Status of and strategies for improving adherence to COPD treatment
147. Evaluation of lung parenchyma, blood vessels, and peripheral blood lymphocytes as a potential source of acute phase reactants in patients with COPD
148. El dilema entre el pulmón y el corazón en EPOC: historia de dos ciudades
149. The Heart–Lung Dilemma in COPD: A Tale of Two Cities
150. Assessing the clinical practice in specialized outpatient clinics for chronic obstructive pulmonary disease: Analysis of the EPOCONSUL clinical audit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.